Potential new targets for chronic liver disease
Fatty liver disease treatments may become more effective after identification and greater understanding of more drug targets.
List view / Grid view
Fatty liver disease treatments may become more effective after identification and greater understanding of more drug targets.
US researchers discover compound that limits weight gain in mice with a high-sugar diet, by lowering the mitochondrial magnesium.
The novel peripheral serotonin antagonist, based on Parkinson’s drug pimavanserin, increased glucose tolerance and lean body mass in a murine model of non-alcoholic fatty liver disease (NAFLD).
Mice given a novel drug that targets a key gene involved in lipid and glucose metabolism were able to tolerate a high-fat diet regimen without developing significant liver damage.
The protein FGFBP3 could be used in the future to reverse disorders associated with metabolic syndrome, such as type 2 diabetes and fatty liver disease...
Researchers have identified a key in the road for the way the liver deals with carbohydrates, fats and protein...